Related Experiment Video
Updated: May 7, 2026
07:31
Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
Published on: May 24, 2016
Syngeneic murine metastasis models: B16 melanoma
Raffaella Giavazzi1, Alessandra Decio
1Department of Oncology, Laboratory of Biology and Therapy of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
Methods in Molecular Biology (Clifton, N.J.)
|October 5, 2013
Summary
The B16 melanoma mouse model is crucial for studying cancer metastasis and developing new therapies. This chapter details methods for inducing lung metastasis in B16 melanoma models.
Area of Science:
- Oncology
- Cancer Metastasis Research
Background:
- The murine B16 melanoma is a widely utilized tumor model in cancer research.
- It is instrumental in elucidating the mechanisms of metastasis and evaluating anticancer treatments.
- This model was initially developed to study lung metastasis.
Purpose of the Study:
- To describe established methodologies for B16 melanoma metastasis research.
- To detail techniques for inducing and analyzing lung metastasis in preclinical models.
Main Methods:
- Intravenous injection of B16 melanoma cells to create artificial lung metastases.
- Analysis of spontaneous metastasis formation after B16 melanoma cell growth in the footpad.
Main Results:
- The described methods allow for the generation of reproducible lung metastasis models using B16 melanoma.
- Different B16 melanoma cell lines exhibit varying metastatic potentials.
Conclusions:
- The B16 melanoma model provides a valuable platform for investigating metastatic processes.
- These methods are essential for the preclinical development of novel anti-cancer therapies targeting metastasis.
